Shandong Keyuan Pharmaceutical Co., Ltd.

¥40.90As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301281Healthcare
Country China
PE (Fwd) •••
TSR 4Y CAGR 13.28%
Div yield 0.12%
ROE 5.08%
Drug Manufacturers (General)
Beta (5Y) 0.39
PE TTM 64.09
TSR TTM 28.58%
Mkt cap ¥4.429B
ROIC 5.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥51
25.57%
3.93%
Hold 12|7|8|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.51
0.55
0.61
0.59
4.77%
11.85%
14.66%
12.17%
Revenue¥M
355.5
374.5
368.7
378.6
8.95%
13.06%
7.38%
8.55%
Peers (US$663.9M)
Cap (US$)
PE
619.8M
46.76x
Capital
TTM
5Y
10Y
Leveragex
1.195
0.048
0.051
EBIT/Intx
1.979
0.295
0.342
Own earn%
30.60
2.85
2.08
Sh yield%
46.19
52.27
52.25
Owners
Insiders/Inst%
4.95
29.27
Short interest%
1.26
SBC / revenue%
3.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
21–26
$1 testx
0.2
Incr. ROIC%
4